Parietal Epithelial Cells (PECs) are specialized cells found in the renal glomerulus, where they line the Bowman's capsule and contribute to the structure and function of the kidney's filtration apparatus. PECs play a crucial role in the formation and maintenance of the glomerular filtration barrier, which selectively filters blood to form urine. PECs are classified into two main types: visceral and parietal. Visceral epithelial cells, also known as podocytes, are part of the filtration barrier and wrap around glomerular capillaries. Parietal epithelial cells, as the name suggests, line the outer layer of Bowman's capsule. While traditionally considered a structural component, recent research indicates that PECs possess some degree of plasticity and may contribute to various aspects of glomerular function and repair. Parietal epithelial cells have been implicated in glomerular disease processes, particularly in conditions leading to glomerulosclerosis. In response to injury, PECs can undergo phenotypic changes, contributing to the development of glomerular scars and fibrosis. PECs are involved in the formation of the Bowman's capsule, which surrounds the glomerulus and captures the filtrate produced during the initial stages of urine formation. This capsule is composed of parietal epithelial cells, creating a structural barrier that is crucial for preventing the loss of essential proteins in the urine. Understanding the roles and plasticity of parietal epithelial cells is essential for unraveling the complexities of glomerular function and pathology. Ongoing research aims to elucidate the molecular mechanisms underlying PEC behavior, with the potential to identify therapeutic targets for kidney diseases. In summary, parietal epithelial cells are integral components of the renal glomerulus, contributing to the structure and function of Bowman's capsule. Their role in glomerular function and involvement in kidney diseases make them a subject of significant interest in nephrology research and potential therapeutic interventions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy